Literature DB >> 17453583

Estimating the impact of alcohol consumption on survival for HIV+ individuals.

R S Braithwaite1, J Conigliaro, M S Roberts, S Shechter, A Schaefer, K McGinnis, M C Rodriguez, L Rabeneck, K Bryant, A C Justice.   

Abstract

Alcohol consumption is associated with decreased antiretroviral adherence, and decreased adherence results in poorer outcomes. However the magnitude of alcohol's impact on survival is unknown. Our objective was to use a calibrated and validated simulation of HIV disease to estimate the impact of alcohol on survival. We incorporated clinical data describing the temporal and dose-response relationships between alcohol consumption and adherence in a large observational cohort (N=2,702). Individuals were categorized as nondrinkers (no alcohol consumption), hazardous drinkers (consume > or =5 standard drinks on drinking days), and nonhazardous drinkers (consume <5 standard drinks on drinking days). Our results showed that nonhazardous alcohol consumption decreased survival by more than 1 year if the frequency of consumption was once per week or greater, and by 3.3 years (from 21.7 years to 18.4 years) with daily consumption. Hazardous alcohol consumption decreased overall survival by more than 3 years if frequency of consumption was once per week or greater, and by 6.4 years (From 16.1 years to 9.7 years) with daily consumption. Our results suggest that alcohol is an underappreciated yet modifiable risk factor for poor survival among individuals with HIV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453583      PMCID: PMC3460376          DOI: 10.1080/09540120601095734

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  37 in total

1.  Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.

Authors:  J H Arnsten; P A Demas; H Farzadegan; R W Grant; M N Gourevitch; C J Chang; D Buono; H Eckholdt; A A Howard; E E Schoenbaum
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

Review 2.  Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?

Authors:  A Cossarizza; C Mussini; A Viganò
Journal:  Bioessays       Date:  2001-11       Impact factor: 4.345

Review 3.  A conceptual framework of frailty: a review.

Authors:  Walter M Bortz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-05       Impact factor: 6.053

4.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

5.  HIV in the United States at the turn of the century: an epidemic in transition.

Authors:  J M Karon; P L Fleming; R W Steketee; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

6.  Problem drinking and medication adherence among persons with HIV infection.

Authors:  R L Cook; S M Sereika; S C Hunt; W C Woodward; J A Erlen; J Conigliaro
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

7.  Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil.

Authors:  L F Brigido; R Rodrigues; J Casseb; D Oliveira; M Rossetti; P Menezes; A J Duarte
Journal:  AIDS Patient Care STDS       Date:  2001-11       Impact factor: 5.078

8.  Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Authors:  Gregory M Lucas; Kelly A Gebo; Richard E Chaisson; Richard D Moore
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

9.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Authors:  Hélène C F Côté; Zabrina L Brumme; Kevin J P Craib; Christopher S Alexander; Brian Wynhoven; Lillian Ting; Hubert Wong; Marianne Harris; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

10.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

View more
  89 in total

1.  HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights.

Authors:  Amin Khademi; Denis Saure; Andrew Schaefer; Kimberly Nucifora; R Scott Braithwaite; Mark S Roberts
Journal:  Value Health       Date:  2015-11-12       Impact factor: 5.725

2.  Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival.

Authors:  Robyn C Neblett; Heidi E Hutton; Bryan Lau; Mary E McCaul; Richard D Moore; Geetanjali Chander
Journal:  J Womens Health (Larchmt)       Date:  2011-01-31       Impact factor: 2.681

3.  Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.

Authors:  Kevin L Kraemer; Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Adam J Gordon; Jonathan Robbins; Susan Zickmund; Kendall Bryant; P Todd Korthuis
Journal:  J Subst Abuse Treat       Date:  2019-05-07

4.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

5.  Alcohol Use, HIV Treatment Adherence, and Sexual Risk Among People with a History of Injecting Drug Use in Vietnam.

Authors:  Li Li; Sitong Luo; Chiao-Wen Lan; Chunqing Lin; Le Anh Tuan; Nan Feng; Nguyen Anh Tuan
Journal:  AIDS Behav       Date:  2017-11

6.  Alcohol use and its association with HIV risk behaviors among a cohort of patients attending HIV clinical care in Tanzania, Kenya, and Namibia.

Authors:  Amy Medley; Puja Seth; Sonal Pathak; Andrea A Howard; Nickolas DeLuca; Eva Matiko; Abubakari Mwinyi; Frieda Katuta; Mushin Sheriff; Neema Makyao; Lucy Wanjiku; Carol Ngare; Pamela Bachanas
Journal:  AIDS Care       Date:  2014-04-29

7.  Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients.

Authors:  Kathleen A McGinnis; Janet P Tate; Emily C Williams; Melissa Skanderson; Kendall J Bryant; Adam J Gordon; Kevin L Kraemer; Stephen A Maisto; Steven Crystal; David A Fiellin; Amy C Justice
Journal:  Drug Alcohol Depend       Date:  2016-09-22       Impact factor: 4.492

8.  Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall.

Authors:  David A Fiellin; Kathleen A McGinnis; Stephen A Maisto; Amy C Justice; Kendall Bryant
Journal:  J Stud Alcohol Drugs       Date:  2013-05       Impact factor: 2.582

9.  Differences in Receipt of Alcohol-Related Care Across Rurality Among VA Patients Living With HIV With Unhealthy Alcohol Use.

Authors:  Kara M Bensley; John Fortney; Gary Chan; Julia C Dombrowski; India Ornelas; Anna D Rubinsky; Gwen T Lapham; Joseph E Glass; Emily C Williams
Journal:  J Rural Health       Date:  2019-01-31       Impact factor: 4.333

10.  Clinicopathologic Features of Colorectal Carcinoma in HIV-Positive Patients.

Authors:  Carlie Sigel; Marcela S Cavalcanti; Tanisha Daniel; Efsevia Vakiani; Jinru Shia; Keith Sigel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-13       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.